BIOMAT Database Logo BIOMAT Database Logo

C1q and immune complexes in liver cirrhosis sera. 1983

H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai

The highest mean value of the serum C1q concentrations among chronic liver diseases was obtained in patients with liver cirrhosis (LC). C1q serum levels seemed to increase along the progression of liver damage. Serum levels of C1q and CH50 in patients with LC and systemic lupus erythematosus (SLE) were simultaneously estimated. No correlation between C1q and CH50 levels was observed in LC sera, while a significant correlation was demonstrated in SLE sera. It could be suggested that the mechanism for the low CH50 in LC sera seemed different from that in SLE sera, and that the activation of classical complement pathway was not the predominant cause in LC sera. Correlations of serum levels between immune complexes and C1q were examined in patients with LC and SLE. It could be deduced from the results of a positive correlation in LC sera and the reverse tendency in SLE sera that the significances of C1q and immune complexes in LC sera differed from those in SLE sera.

UI MeSH Term Description Entries
D008103 Liver Cirrhosis Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. Cirrhosis, Liver,Fibrosis, Liver,Hepatic Cirrhosis,Liver Fibrosis,Cirrhosis, Hepatic
D008105 Liver Cirrhosis, Biliary FIBROSIS of the hepatic parenchyma due to obstruction of BILE flow (CHOLESTASIS) in the intrahepatic or extrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC; BILE DUCTS, EXTRAHEPATIC). Primary biliary cholangitis involves the destruction of small intra-hepatic bile ducts and decreased bile secretion. Secondary biliary cholangitis is produced by prolonged obstruction of large intrahepatic or extrahepatic bile ducts from a variety of causes. Biliary Cirrhosis,Biliary Cirrhosis, Primary,Biliary Cirrhosis, Secondary,Cholangitis, Chronic Nonsuppurative Destructive,Liver Cirrhosis, Obstructive,Primary Biliary Cholangitis,Biliary Cirrhosis, Primary, 1,Primary Biliary Cirrhosis,Secondary Biliary Cholangitis,Secondary Biliary Cirrhosis,Biliary Cholangitides, Primary,Biliary Cholangitis, Primary,Biliary Cholangitis, Secondary,Cholangitides, Primary Biliary,Cholangitis, Primary Biliary,Cholangitis, Secondary Biliary,Cirrhosis, Biliary,Cirrhosis, Secondary Biliary,Liver Cirrhoses, Biliary,Obstructive Liver Cirrhosis,Primary Biliary Cholangitides,Secondary Biliary Cholangitides
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D003166 Complement Activating Enzymes Enzymes that activate one or more COMPLEMENT PROTEINS in the complement system leading to the formation of the COMPLEMENT MEMBRANE ATTACK COMPLEX, an important response in host defense. They are enzymes in the various COMPLEMENT ACTIVATION pathways. Activating Enzymes, Complement,Enzymes, Complement Activating
D003171 Complement Pathway, Classical Complement activation initiated by the binding of COMPLEMENT C1 to ANTIGEN-ANTIBODY COMPLEXES at the COMPLEMENT C1Q subunit. This leads to the sequential activation of COMPLEMENT C1R and COMPLEMENT C1S subunits. Activated C1s cleaves COMPLEMENT C4 and COMPLEMENT C2 forming the membrane-bound classical C3 CONVERTASE (C4B2A) and the subsequent C5 CONVERTASE (C4B2A3B) leading to cleavage of COMPLEMENT C5 and the assembly of COMPLEMENT MEMBRANE ATTACK COMPLEX. Classical Complement Pathway,Classical Complement Activation Pathway,Complement Activation Pathway, Classical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune
D015922 Complement C1q A subcomponent of complement C1, composed of six copies of three polypeptide chains (A, B, and C), each encoded by a separate gene (C1QA; C1QB; C1QC). This complex is arranged in nine subunits (six disulfide-linked dimers of A and B, and three disulfide-linked homodimers of C). C1q has binding sites for antibodies (the heavy chain of IMMUNOGLOBULIN G or IMMUNOGLOBULIN M). The interaction of C1q and immunoglobulin activates the two proenzymes COMPLEMENT C1R and COMPLEMENT C1S, thus initiating the cascade of COMPLEMENT ACTIVATION via the CLASSICAL COMPLEMENT PATHWAY. C1q Complement,Complement 1q,Complement Component 1q,C1q, Complement,Complement, C1q,Component 1q, Complement

Related Publications

H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
C1q-bearing immune complexes detected by a monoclonal antibody to human C1q in rheumatoid arthritis sera and synovial fluids.
January 1991, Rheumatology international,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
Immune complexes in the choroid plexus in liver cirrhosis.
March 1991, Archives of pathology & laboratory medicine,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
Immune complexes in syphilis sera.
September 1981, Journal of immunology (Baltimore, Md. : 1950),
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
[Localization of immune complexes in the liver in experimental cirrhosis].
January 1981, Arkhiv patologii,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
[Demonstration of circulating soluble immune complexes in the sera of psoriatic patients using the 125I-C1q deviation test].
December 1977, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
Effects of single-stranded DNA on circulating immune complexes in SLE sera detected by C1q solid-phase assay.
January 1985, Archives of dermatological research,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
C1q-containing immune complexes purified from sera of juvenile rheumatoid arthritis patients mediate IL-8 production by human synoviocytes: role of C1q receptors.
October 1999, Journal of immunology (Baltimore, Md. : 1950),
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
Differences among immune complexes: association of C1q in SLE immune complexes with renal disease.
February 1987, Journal of immunology (Baltimore, Md. : 1950),
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
C1q microtiter plate ELISA system for detecting circulating immune complexes and its application of testing the sera in neurological diseases.
February 1984, The Japanese journal of experimental medicine,
H Yoshida, and M Sato, and S Watanabe, and T Nishimaki, and T Morito, and R Kasukawa, and M Nakai
Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
September 1987, Journal of immunological methods,
Copied contents to your clipboard!